Researchers at Griffith University‘s Eskitis Institute have developed a new technique for discovering natural compounds which could form the basis of novel therapeutic drugs. The Parkinson’s response is just the start.
The corresponding author, Professor Ronald Quinn AM said testing the new process on a marine sponge had delivered not only confirmation that the system is effective, but also a potential lead in the fight against Parkinson’s disease.
“We have found a new screening method which allows us to identify novel molecules drawn from nature to test for biological activity,” Professor Quinn said.
“As it happens, the first new compound we discovered through this process has demonstrated a response in Parkinson’s disease cells.”
Prestigious chemistry journal Angewandte Chemie has published the results in “NMR Fingerprints of the Drug-like Natural Product Space: Iotrochotazine A, a Chemical Probe to Study Parkinson’s Disease”.
The first author Dr Tanja Grkovic said the screening process involves nuclear magnetic resonance (NMR) spectroscopy; a highly sensitive instrument through which it is possible to see natural products weighing as little as 20 micrograms, which is less than a grain of salt.
“When you are searching for nature-derived molecules, the jackpot is finding something that nobody has ever seen before and rather than just a variation on a known theme,” Dr Grkovic said.
“We began the project by selecting 20 marine sponge samples randomly from Griffith’s Nature Bank facility and using the NMR technique trying to visualise all the small molecules which could meet the requirements for a potential new drug.
“The idea was to look at patterns of data and identify unusual or unique sets. We followed one such pattern and isolated a natural product with a novel skeleton which has turned out to be a molecule which was completely unknown previously.”
Griffith’s Nature Bank is a unique drug discovery resource based on natural products found in Australia, China and Papua New Guinea. It comprises more than 45,000 samples of plants and marine invertebrates, 200,000 semi-purified fractions, 3,250 pure compounds and over 600 naturally-occurring fragments.
This NMR screening process provides a new way of searching all those natural samples stored in Nature Bank and uncovering the potential biological activity of the compounds within them.
Deputy Director of the Eskitis Institute and co-author of the paper, Associate Professor George Mellick, is a specialist researcher in neurodegenerative diseases such as Parkinson’s disease. He is delighted by the research prospects this new molecule may provide.
“What is very intriguing about this novel natural product is that, while we have found it has an effect on cells sourced from a Parkinson’s patient, it showed a different biological activity on cells from healthy individuals,” Associate Professor Mellick said.
“This provides us with a new tool to study the fundamental biology of Parkinson’s and to get a better understanding of the cellular processes involved in the development of this disease.
But the Parkinson’s response is just the start.
“This new research technique opens the door to unlimited opportunities, both in terms of chemistry and biology research at Eskitis, as we continue the search for new therapies against disease,” Professor Quinn said.
The Latest on: New drugs from nature
via Google News
The Latest on: New drugs from nature
- New treatment could ease the passage of kidney stoneson December 2, 2019 at 8:05 am
then a new student in MIT's Health Sciences and Technology program, met with Cima to discuss possible thesis projects and became interested in pursuing a kidney stone treatment. "If you look at how ...
- Prescription opioids destroyed families. Now, victims worry addiction stigma may keep them from getting justice.on December 2, 2019 at 7:27 am
The claim said Purdue Pharma failed to warn him and other plaintiffs about the addictive nature of the drug. But a U.S. district court judge disagreed in 2003 ... Because it was the first company to ...
- New principle for activation of cancer genes discoveredon December 2, 2019 at 5:46 am
The findings, published in Nature Genetics, create conditions for brand new strategies to fight cancer ... "Since the principle is specific for cancer cells, this opens the possibility of new targeted ...
- A new method for pharmaceutical compounding and storage of anti-VEGF biologics for intravitreal use in silicone oil-free prefilled plastic syringeson December 2, 2019 at 2:28 am
The diseases are chronic in their nature, and most patients need long-term therapy to suppress disease activity. We previously reported a compounding method for repackaging and storage of aflibercept ...
- New technique could help produce uniform nanoparticles for use in drug delivery systemson November 27, 2019 at 10:07 am
To date, however, only a handful of nanoparticle-based drugs have succeeded in reaching the clinic. This is because of the challenges in controlling the size and shape of nanoparticles - and ...
- New flu drug drives drug resistance in influenza viruseson November 26, 2019 at 5:10 am
He and colleagues describe this in a study published today [Nov. 25, 2019] in Nature Microbiology that examined the effects of baloxavir ... and transmitted from brother to sister,” Kawaoka explains.
- New Roche flu drug can drive resistance in influenza viruses: researcherson November 25, 2019 at 10:53 am
CHICAGO (Reuters) - Roche’s influenza treatment Xofluza, a one-dose pill that can clear flu symptoms within days, may cause a mutation of the virus that leads to drug resistance, researchers reported ...
- New virus-inspired method to deliver drugs to brain developed: Studyon October 12, 2019 at 5:29 am
The study, published in the journal Nature Communications, noted that the new method allowed for combination drug delivery through an intravenous injection to cross the blood-brain-barrier (BBB). The ...
- IIT Guwahati researchers develop nature-derived nanomaterials for targeted delivery of cancer drugson September 26, 2019 at 1:29 am
GUWAHATI: Indian Institute of Technology Guwahati (IIT Guwahati) researchers have developed nanomaterials derived from nature to deliver ... use as carriers in targeted drug delivery. The concept of ...
- PastCast: Monoclonal antibodies, from basic science to blockbuster drugson August 30, 2019 at 6:38 am
In the Nature PastCast series ... Between 1997 and 2011, the Food and Drugs Administration approved between one and four new monoclonal antibodies per year. Amongst those antibodies were Rituxan or ...
via Bing News